KB cells express a folate-binding protein that is anchored to the plasma membrane by a glycosylated phosphatidylinositol (GPI) tail and these cells can grow in medium containing a very low folate concentration (1 nM). In contrast, mouse 3T3 cells do not express a membrane-associated folate-binding protein and cannot grow under similar low folate conditions. In these studies, 3T3 cells were transfected with a vector containing the cDNA that codes for the KB cell folate-binding protein. In contrast to the wild-type 3T3 cells, the transfected 3T3 cells express a level of folate-binding protein similar to KB cells, 1 and 1.4 ng/,ug protein, respectively. The capacity for binding 13HI
Introduction
Two forms of human folate-binding protein (FBP),' a soluble and a membrane-associated form, have been identified in the cytosol and membranes of a variety of cells and in biologic 1 . Abbreviations used in this paper: CAT, chloramphenicol acetyltransferase; FBC, folate binding capacity, FBP, folate-binding protein; FD and FR, folate deficient and folate replete; GPI, glycosylated phosphatidylinositol; PCR, polymerase chain reaction; PI-PLC, phospholipase C specific for phosphatidylinositol; THF, tetrahydrofolate.
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Volume 90, September 1992, 840-847 fluids such as milk and plasma ( 1, 2) . The KB cell, a cultured cell line derived from a human epidermoid carcinoma, has a high level ofexpression ofa membrane FBP, a small fraction of which is released as a soluble form into the culture medium (3) (4) (5) . We have recently demonstrated that the membrane FBP in KB cells is a member of a unique group ofproteins that is anchored to the plasma membrane by a glycosylated phosphatidylinositol (GPI) tail, rather than by a transmembrane hydrophobic peptide (6) . A similar GPI-linked FBP has been identified by Lacey and co-workers in MA 104 cells, a monkey kidney epithelial cell line (7) .
Several other cell lines, such as L1210 (8) (9) (10) and CCRF-CEM ( 11 ) leukemia cells, have been described in which a highaffinity FBP, undetectable in the parental cell line, is induced after selection of cells in low folate medium. However, unlike these cell lines, KB cells survive without selection in medium containing a low concentration of folate (1 nM), i.e., 2,000-fold less than contained in normal, folate-replete medium (2.3 ,uM) (3) (4) (5) . Although the GPI-anchored FBP has a higher affinity for oxidized than reduced folates, it has been demonstrated that this membrane FBP in KB cells mediates the uptake of the physiologic folate, 5-methyltetrahydrofolate (5-methyl THF) (12, 13) . For these reasons, it has been postulated that the GPI-anchored membrane FBP of KB cells provides a mechanism for the uptake of folate when the concentration offolate in the medium is very low and this results in the survival of KB cells under conditions of relative folate depletion.
However, because the intracellular concentration of folate in KB cells cultured under such folate deficient conditions is very low, it is also possible that the ability to survive in folatedeficient medium may be the consequence of an epiphenomenon in this carcinoma-derived cell line which is independent of the membrane-associated FBP or which is an additional adaptation in concert with the expression of the FBP.
To address this question, we have transfected the cDNA encoding the FBP in KB cells ( 14) into mouse 3T3 cells, a cell line that does not express a membrane FBP and cannot survive under folate-deficient conditions. This has provided the opportunity to study the growth characteristics under conditions of folate depletion and folate excess in the transfected and wildtype cells without requiring the selection ofcells by slow conditioning in culture medium containing low folate which could lead to other adaptations in intracellular folate metabolism.
Methods

Materials
The KB cell line, derived from an epidermoid carcinoma, and the murine 3T3 cell line were purchased from the American Type Culture Collection (Rockville, MD). Dulbecco's minimal essential medium (DME), specially prepared without folic acid and methionine was obtained from Gibco Laboratories (Grand Island, 
Methods
Construction ofthe vector (pCAR 1 7) for transfection ofthe cDNA encoding the FBP in KB cells. Because the cDNA for the KB cell FBP cloned in our laboratory lacked the full-length nucleotide sequence encoding the signal peptide ( 14) , the nucleotide sequence for this region ofthe protein, as determined by Elwood ( 16) for the same cDNA, was prepared by reverse transcription from KB cell poly(A)+ RNA, followed by amplification of the 5' coding fragment by the polymerase chain reaction (PCR) using specific oligonucleotides encompassing this domain. The integrity ofthe amplified fragment was confirmed by DNA sequencing.
The specific steps for the construction of this vector are as follows: Oligonucleotide (RD7-22C) contains an Nco I restriction site (underlined) in the 5' portion of the FBP signal sequence with the initiation codon shown in bold print. Its sequence is:
Oligonucleotide (RD8-18C) contains a Sal I restriction site (underlined) and is complementary to a coding sequence within the FBP cDNA beginning 163 bp downstream from the ATG start site. Its sequence is:
Whole-cell KB mRNA was incubated with oligo RD8-1 8C and the murine leukemia virus reverse transcriptase for 30 min at 42°C, thereby synthesizing RNA-DNA hybrids from FBP mRNA. This reaction was performed in PCR buffer (Cetus Corp., Emeryville, CA), 200 MM dNTPs, and I MM of the oligonucleotide RD8-1 8C. To this mixture, 5 U of Taq DNA polymerase, the primer RD7-22C (to attain a final concentration of 1 ,uM), and 50 Ml paraffin oil were added. The reaction was incubated according to the following schedule: 5.0 min at 94°C (one cycle); 1.5 min at 94°C, 2.5 min at 50°C, 3.5 min at 72°C (35 cycles); and 10 min at 72°C (one cycle).
The reaction product was extracted twice into chloroform/isoamyl alcohol (24:1), precipitated in ethanol, resuspended in 30 Ml 10 mM Tris/ 1 mM EDTA, pH 7.5, and 2 ul were subjected to electrophoresis in a 1.2% agarose gel to determine the yield.
The PCR fragment was cut with Nco I and Sal I and replaced the truncated 5' end of the original cDNA which had been cloned in the Eco RI site of a pUC18 derivative. The FBP cDNA in this pUC 18 derivative had been previously modified to add the Kozak consensus sequence, which provided the Nco I restriction site into which the processed PCR-generated fragment was cloned. This complete cDNA coding region was then excised at flanking Sma I and Tha I sites and cloned between the Stu I and Sma I sites of pYZ28 (17, 18) . The resulting plasmid, pCAR 17, contains the FBP cDNA sequence between an SV40 early promoter and polyadenylation signals (Fig. 1) (20) .
Southern blotting oftransfected and wild-type 3T3 cells. Chromosomal DNA from the cultured cells ( 15 x 106 cells) was prepared by a standard method of phenol/chloroform extraction and ethanol precipitation ( 19) . The DNA (lOug) was digested with Nco I, which is the linker restriction site for the insertion of the FBP cDNA into the transfection construct site in pCAR 17, and then subjected to electrophoresis in 1% agarose and Southern blotting (21 ) using the FBP cDNA as the probe.
Cell culture. Normal, folate-replete (FR) KB cells, and wild-type and transfected 3T3 cells were maintained as adherent cell monolayers in DME which contained 2.26 MM folate, as previously described (5). These cells were made folate deficient (FD) by culturing in DME containing 1 nM folate. Both FR and FD media were supplemented with 10% FCS, 2 mM L-glutamine, penicillin ( 100 U/ml), and streptomycin (100Mgg/ml).
Measurement ofthefolate binding capacity (FBC) and total FBP.
The cultured cells were released from the monolayer by incubation with 0.25% trypsin at 37°C for 2 min, washed three times in HBSS at 4°C and solubilized in 0.01 M K phosphate/ 1% Triton X-100, pH 7.4.
The unsaturated FBC of the solubilized cells was determined by the binding of [ 3H ]folic acid using dextran-coated charcoal to remove unbound ligand as previously described (5). The total FBC was determined in a similar manner after removal ofendogenous folate by dialysis of the solubilized cells against 0.01 M acetic acid/ 1% Triton X-100 for 4 h followed by dialysis against 0.01 M K Phosphate, pH 7.4 for 4 h. The total FBP (apo and holo forms) in these fractions was determined by noncompetitive radioimmunoassay (20) . PI-PLC treatment ofintact cells. The media from the FD KB and the FD 3T3 monolayers were removed, the cell monolayers were then washed three times with HBSS and 1 ml ofFD DME containing 2 mM glutamine, 10% dialyzed FCS, and PI-PLC (3 U/ml) was added. Control monolayer cells were treated similarly with the exception that no PI-PLC was added to the incubation medium. After a 6 h incubation at 37°C, the medium was removed and the monolayers washed three times with HBSS. The cells were then released from the monolayer by incubation with 0.25% trypsin at 37°C for 2 min, washed three times with HBSS at 4°C, and suspended in 1 ml ofHBSS. Under these conditions, cell 8 .0, and saved at -35°C. On the day of the folate assay, an aliquot ofthe cell suspension was removed for the determination of protein concentration and the remainder ofthe preparation was boiled for 10 min, the insoluble debris was pelleted by centrifugation at 12,000 g for 5 min and the supernatant was assayed for folate using the sequential noncompetitive radioassay described by Rothenberg et al. (22) . The standard for the dose-response curve was (6S)-N5-methyl THF. Oxidized and reduced folate monoglutamates and polyglutamates react similarly in this noncompetitive assay system except for N5-formyl THF, the intracellular concentration of which is very low (23) .
The total cellular protein concentration was measured by bicinchoninic acid protein assay reagent as described by the manufacturer.
Purification ofthe membrane FBPfrom transfected 3T3 cells. The membrane FBP was purified from cells cultured in FD medium using an epoxy-activated Sepharose 6B matrix coupled to folate (24) , as previously described (5, 25) .
[ (Fig. 3, columns 2 and 4) . The total FBP of the transfected 3T3 cells did not increase when these cells were cultured in FD medium for 4 mo (column 3) (1.36 ng/,ug Triton solubilized protein). In contrast, the total FBP of KB cells did increase when these cells were cultured in FD medium (column 5) (6 ng/Ag Triton solubilized protein) and this has been previously reported by our laboratory and others (3) (4) (5) (Fig. 4) The concentration of total folate in these cells is shown in Table I . In cells cultured in FD medium, the level of folate in wild-type and CAT transfected 3T3 cells was significantly lower (< 0.05 pmol/mg total cell protein for both) than the levels of folate in the FBP transfected 3T3 cells and KB cells 4) . In the KB cell line, the 32-kD species was replaced by a broader 38-kD band (lane 6). Thus, the difference in the apparent molecular weights of the FBPs purified from the FBP transfected 3T3 cells and KB cells is not due to a difference in the molecular weights of the peptides but rather it is due to a difference in post-translational processing, probably involving complex glycosylation (29) .
Discussion
We provide evidence in this report for the stable transfection of a murine 3T3 cell line with the cDNA for a human FBP and the expression of a functional and structurally similar protein to the one expressed by KB cells from which the cDNA was cloned (7, 14, 16) . We also show that the FBP expressed in the transfected cells is: (a) localized to the plasma membrane; (b) susceptible to PI-PLC cleavage and therefore, GPI- deoxythymidine monophosphate, the methylation of homocysteine to form methionine, glycine-serine interconversion, and the metabolism of histidine (30 (8-1 1 ) . This is evidence that the two phenomena, expression ofthe GPI-linked FBP and survival in low folate medium, are cause-and-effect related.
It is of interest that although the expression of the GPIlinked FBP in KB cells increases when these cells are cultured in low folate medium (3) (4) (5) , no similar increase is observed in the transfected 3T3 cells. Two factors may explain this observation. First, since the incorporation of the transfected vector into the host genome is a random process, the location of the cDNA may not be in a favorable cis orientation to a regulatory element responsive to the low folate environment. Second (32) and capable of erythroid differentiation, do not express a membrane-anchored FBP and the doubling time of these cells increases as intracellular folate decreases.
Although it is evident that the membrane FBP mediates folate transport and is of critical importance in the survival of cells in low folate medium, how it functions in the transport of the physiologic folate, 5-methyl THF, is unclear. In most cultured cell lines, reduced folates enter the cell via a transmembrane channel (33) which is inhibited by probenicid and other anions (33-35). Kamen and co-workers have postulated that the GPI-linked membrane FBP is coupled to the reduced folate transmembrane channel by demonstrating that after binding to the GPI-linked FBP of MA 104 cells, the movement of 5-methyl THF into the cytosol is inhibited by probenicid (36) . Since the GPI anchor of the FBP results in increased mobility of the protein in the plasma membrane (28) , the FBP may function by concentrating folate in close proximity to a reduced folate channel through which 5-methyl THF enters the cytoplasm after it dissociates from the FBP. In support of this hypothesis, clustering of the FBP in invaginations of the plasma membrane called caveolae has been observed (37, 38) . However, Westerhofand co-workers concluded from their studies (39) that these two transport systems, the membrane FBP and the reduced folate channel, transport reduced folates independently in L1210-B73 cells, a variant of murine leukemia L12 10 cells grown in low folate medium, because folate did not inhibit the uptake ofmethotrexate which is internalized via the reduced folate channel. It is unlikely that the GPI-linked FBP transports folate through the cell membrane by providing a transmembrane channel, since it is anchored in the outer leaflet of the plasma membrane by the GPI tail which places the folate binding site at a distance from the cell surface.
